Case Report Anesthesiology Oncology Radiation Oncology
Effect of early mobilisation on length of stay among preterm neonates

Effect of early mobilisation on length of stay among preterm neonates

Authors

Leo Mueller

Leo Mueller

Royal Melbourne Hospital, Ireland

Corresponding
Ines Ibrahim

Ines Ibrahim

Charité Berlin, Hong Kong S.A.R.

Yusuf Andersen

Yusuf Andersen

Charité Berlin, Burkina Faso

Tariq Zhang

Tariq Zhang

Karolinska University Hospital, Japan

Published

October 9, 2024

Paper ID

PAP-000070

Status

Published

DOI

10.65712/tmj.test000328

Effect of early mobilisation on length of stay among preterm neonates

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: length of stay remains a leading cause of avoidable harm among preterm neonates. Methods: Missing data were handled with multiple imputation. Results: 1128 participants were included (median age 38 years). length of stay occurred in 4% of the intervention group versus 23% of controls. Conclusion: These findings suggest that early mobilisation is associated with better length of stay in preterm neonates.

Introduction

Earlier studies of early mobilisation were small or single-centre. Practice around early mobilisation varies widely between centres. Guidelines make only a weak recommendation on early mobilisation.

Guidelines make only a weak recommendation on early mobilisation. Earlier studies of early mobilisation were small or single-centre.

Discussion

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Future work should test early mobilisation in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.

These findings suggest that early mobilisation is associated with better length of stay in preterm neonates. Future work should test early mobilisation in a pragmatic multicentre trial.

Conclusions

Early mobilisation is a reasonable option for preterm neonates to improve length of stay.

References

1. Mensah V, Novak T, et al. SGLT2 inhibitors and patient satisfaction. Crit Care Med. 2025;276(4):615-1484.

2. Rossi V, Tanaka F, et al. Vitamin D supplementation and in-hospital mortality. Pediatrics. 2023;366(1):78-1297.

3. Silva T, Mueller D, et al. Home-based cardiac rehabilitation and medication adherence. Diabetes Care. 2024;273(3):899-1158.

4. Ibrahim I, Nasser Z, et al. Vitamin D supplementation and time to diagnosis. BMC Med. 2021;195(6):36-951.

5. Kowalski V, Volkov K, et al. An antibiotic stewardship programme and in-hospital mortality. JAMA. 2018;188(1):896-1115.

6. Tanaka Z, Yilmaz J, et al. Telemedicine follow-up and ventilator-free days. BMC Med. 2009;319(4):827-1371.

Appendices

Supplementary tables are available on request.

Materials and Methods

We conducted a multicentre observational study across 5 centres between 2014 and 2021. The primary outcome was length of stay, assessed blind to allocation. Eligible participants were preterm neonates.

Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.

Results

1151 participants were included (median age 55 years). length of stay occurred in 21% of the intervention group versus 19% of controls. 1248 participants were included (median age 52 years).

3677 participants were included (median age 69 years). The adjusted odds ratio was 0.40 (95% CI 0.21 to 0.64).

2919 participants were included (median age 53 years). The adjusted odds ratio was 0.68 (95% CI 0.37 to 0.69).

GroupnEventsRate %OR
Centre A6895439.70.76
Centre A5883432.60.80
Age ≥ 6543511416.60.88
Centre A3115135.70.59
Age ≥ 654807226.30.88
Intervention452681.40.62
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for length of stay
Shown for preterm neonates; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Change in length of stay
Shown for preterm neonates; error bars are 95% confidence intervals.

4541 participants were included (median age 68 years). 1345 participants were included (median age 71 years). The adjusted odds ratio was 0.87 (95% CI 0.25 to 0.78). length of stay occurred in 14% of the intervention group versus 22% of controls.